TRIM5 and Hepatic fibrosis: The aim of this study was to analyze whether TRIM5 and TRIM22 polymorphisms are associated with liver fibrosis inflammation-related biomarkers and response to pegIFNα/RBV therapy in HIV/HCV coinfected patients.